Back
Compass Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
79
CMPX
Compass Therapeutics, Inc.
Last Price:
$6.29
Seasonality Move:
-7.27%
7 Day Trial
ALL ACCESS PASS
$
7
Compass Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 78.5% based on the past 4 years of stock performance.
-
Compass Therapeutics, Inc. has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Compass Therapeutics, Inc. Stock Undervalued?The current Compass Therapeutics, Inc. [CMPX] share price is $6.28. The Score for CMPX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
CMPX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Compass Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 78.5% based on the past 4 years of stock performance.
Compass Therapeutics, Inc. Stock Rating
Buy
79
Compass Therapeutics, Inc. (CMPX)
is a Buy
Is Compass Therapeutics, Inc. overpriced?
-
Compass Therapeutics, Inc. has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Compass Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
compasstherapeutics.com
52-Week Data
52-Week High:
6.88
52-Week Low:
1.33
Prediction Charts
Market Cap:
1.1B
Price in USD:
6.28
Volume:
2.5M
Beta:
1.27
Technical Analysis
SMA50:
5.67
SMA100:
4.96
SMA200:
3.84
52-Wk Change:
82.03%
Stock Predictions
-
Is Compass Therapeutics, Inc. stock public?Yes, Compass Therapeutics, Inc. is a publicly traded company.
-
What is the Compass Therapeutics, Inc. stock quote today?The Compass Therapeutics, Inc. stock price is 6.28 USD today.
-
How to buy Compass Therapeutics, Inc. stock online?You can buy Compass Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 6.16 | 6.41 | 6.48 | 6.13 |
| Jan-28 | 6.45 | 6.16 | 6.49 | 6.05 |
| Jan-29 | 6.17 | 6.38 | 6.44 | 6.06 |
| Jan-30 | 6.29 | 6.40 | 6.47 | 6.21 |
| Feb-2 | 6.39 | 6.52 | 6.71 | 6.38 |
| Feb-3 | 6.59 | 6.42 | 6.88 | 6.25 |
| Feb-4 | 6.65 | 6.33 | 6.67 | 6.25 |
| Feb-5 | 6.27 | 6.22 | 6.56 | 6.20 |
| Feb-6 | 6.35 | 6.52 | 6.69 | 6.29 |
| Feb-9 | 6.50 | 6.69 | 6.82 | 6.40 |
| Feb-10 | 6.79 | 6.60 | 6.82 | 6.52 |
| Feb-11 | 6.60 | 6.44 | 6.67 | 6.29 |
| Feb-12 | 6.44 | 6.34 | 6.50 | 6.26 |
| Feb-13 | 6.53 | 6.28 | 6.60 | 6.21 |
Compass Therapeutics, Inc. Earnings
Compass Therapeutics, Inc. Earnings Report: Per Share Compass Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Compass Therapeutics, Inc. Forecast Revenue Growth
Compass Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Compass Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.06 per share.
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.